Literature DB >> 16262255

Ubiquitination of p21Cip1/WAF1 by SCFSkp2: substrate requirement and ubiquitination site selection.

Wei Wang1, Lucas Nacusi, Robert J Sheaff, Xuedong Liu.   

Abstract

Multiple proteolytic pathways are involved in the degradation of the cyclin-dependent kinase inhibitor p21(Cip1/WAF1). Timed destruction of p21(Cip1/WAF1) plays a critical role in cell-cycle progression and cellular response to DNA damage. The SCF(Skp2) complex (consisting of Rbx1, Cul1, Skp1, and Skp2) is one of the E3 ubiquitin ligases involved in ubiquitination of p21(Cip1/WAF1). Little is known about how SCF(Skp2) recruits its substrates and selects particular acceptor lysine residues for ubiquitination. In this study, we investigated the requirements for SCF(Skp2) recognition of p21(Cip1/WAF1) and lysine residues that are ubiquitinated in vitro and inside cells. We demonstrate that ubiquitination of p21(Cip1/WAF1) requires a functional interaction between p21(Cip1/WAF1) and the cyclin E-Cdk2 complex. Mutation of both the cyclin E recruitment motif (RXL) and the Cdk2-binding motif (FNF) at the N terminus of p21(Cip1/WAF1) abolishes its ubiquitination by SCF(Skp2), while mutation of either motif alone has minimal effects, suggesting either contact is sufficient for substrate recruitment. Thus, SCF(Skp2) appears to recognize a trimeric complex consisting of cyclin E-Cdk2-p21(Cip1/WAF1). Furthermore, we show that p21(Cip1/WAF1) can be ubiquitinated at four distinct lysine residues located in the carboxyl-terminal region but not two other lysine residues in the N-terminal region. Any one of these four lysine residues can be targeted for ubiquitination in the absence of the others in vitro, and three of these four lysine residues are also ubiquitinated in vivo, suggesting that there is limited specificity in the selection of ubiquitination sites. Interestingly, mutation of the carboxyl-terminal proline to lysine enables ubiquitin conjugation at the carboxyl terminus of the substrate both in vitro and in vivo. Thus, our results highlight a unique property of the ubiquitination enzymatic reaction in that substrate ubiquitination site selection can be remarkably diverse and occur in distinct spatial areas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16262255     DOI: 10.1021/bi051071j

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  33 in total

1.  Growth inhibition by miR-519 via multiple p21-inducing pathways.

Authors:  Kotb Abdelmohsen; Subramanya Srikantan; Kumiko Tominaga; Min-Ju Kang; Yael Yaniv; Jennifer L Martindale; Xiaoling Yang; Sung-Soo Park; Kevin G Becker; Murugan Subramanian; Stuart Maudsley; Ashish Lal; Myriam Gorospe
Journal:  Mol Cell Biol       Date:  2012-04-30       Impact factor: 4.272

2.  Targeting p21 degradation locally.

Authors:  Yue Xiong
Journal:  Dev Cell       Date:  2010-11-16       Impact factor: 12.270

3.  APC/C(Cdc20) controls the ubiquitin-mediated degradation of p21 in prometaphase.

Authors:  Virginia Amador; Sheng Ge; Patricia G Santamaría; Daniele Guardavaccaro; Michele Pagano
Journal:  Mol Cell       Date:  2007-08-03       Impact factor: 17.970

4.  MDMX promotes proteasomal turnover of p21 at G1 and early S phases independently of, but in cooperation with, MDM2.

Authors:  Yetao Jin; Shelya X Zeng; Xiao-Xin Sun; Hunjoo Lee; Christine Blattner; Zhixiong Xiao; Hua Lu
Journal:  Mol Cell Biol       Date:  2007-12-17       Impact factor: 4.272

5.  CDK inhibitor p21 is degraded by a proliferating cell nuclear antigen-coupled Cul4-DDB1Cdt2 pathway during S phase and after UV irradiation.

Authors:  Hideo Nishitani; Yasushi Shiomi; Hiroka Iida; Masato Michishita; Toshihiro Takami; Toshiki Tsurimoto
Journal:  J Biol Chem       Date:  2008-08-14       Impact factor: 5.157

Review 6.  Mechanism of CRL4(Cdt2), a PCNA-dependent E3 ubiquitin ligase.

Authors:  Courtney G Havens; Johannes C Walter
Journal:  Genes Dev       Date:  2011-08-01       Impact factor: 11.361

7.  Hdm2- and proteasome-dependent turnover limits p21 accumulation during S phase.

Authors:  Daniel Ciznadija; Xin-Hua Zhu; Andrew Koff
Journal:  Cell Cycle       Date:  2011-08-15       Impact factor: 4.534

Review 8.  Ubiquitination of substrates by esterification.

Authors:  Xiaoli Wang; Roger A Herr; Ted H Hansen
Journal:  Traffic       Date:  2011-09-13       Impact factor: 6.215

9.  Basal p21 controls population heterogeneity in cycling and quiescent cell cycle states.

Authors:  K Wesley Overton; Sabrina L Spencer; William L Noderer; Tobias Meyer; Clifford L Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-29       Impact factor: 11.205

Review 10.  p21 in cancer: intricate networks and multiple activities.

Authors:  Tarek Abbas; Anindya Dutta
Journal:  Nat Rev Cancer       Date:  2009-06       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.